Energy Metabolism in Uncoupling Protein 3 Gene Knockout Mice by Vidal-Puig, A. et al.
The University of San Francisco
USF Scholarship: a digital repository @ Gleeson Library |
Geschke Center
Biology Faculty Publications Biology
2000
Energy Metabolism in Uncoupling Protein 3 Gene
Knockout Mice
A. Vidal-Puig
D. Grujic
C. Zhang
T. Hagen
O. Boss
See next page for additional authors
Follow this and additional works at: http://repository.usfca.edu/biol_fac
Part of the Biology Commons
This Article is brought to you for free and open access by the Biology at USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. It
has been accepted for inclusion in Biology Faculty Publications by an authorized administrator of USF Scholarship: a digital repository @ Gleeson
Library | Geschke Center. For more information, please contact repository@usfca.edu.
Recommended Citation
Vidal-Puig, A., Grujic, D., Zhang, C., Hagen, T., Boss, O., Ido, Y., Szczepanik, A., Wade, J., Mootha, V., Cortright, R., Muoio, D.M.,
Lowell, B.B. (2000). Energy metabolism in uncoupling protein 3 gene knockout mice. Journal of Biological Chemistry, 275(21),
16258-16266. http://0-dx.doi.org.ignacio.usfca.edu/10.1074/jbc.M910179199
Authors
A. Vidal-Puig, D. Grujic, C. Zhang, T. Hagen, O. Boss, Y. Ido, A. Szczepanik, Jennifer Wade, V. Mootha, R.
Cortright, D. M. Muoio, and B. B. Lowell
This article is available at USF Scholarship: a digital repository @ Gleeson Library | Geschke Center: http://repository.usfca.edu/
biol_fac/43
Energy Metabolism in Uncoupling Protein 3 Gene Knockout Mice*
Received for publication, December 22, 1999, and in revised form, March 15, 2000
Published, JBC Papers in Press, March 22, 2000, DOI 10.1074/jbc.M910179199
Antonio J. Vidal-Puig‡§, Danica Grujic‡, Chen-Yu Zhang‡, Thilo Hagen‡, Olivier Boss‡,
Yasuo Ido¶, Alicja Szczepanik‡, Jennifer Wade‡, Vamsi Mootha‡, Ronald Cortrighti,
Deborah M. Muoioi, and Bradford B. Lowell‡**
From the ‡Division of Endocrinology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard
Medical School, Boston, Massachusetts 02215, iDepartments of Exercise and Sports Science Physiology and Biochemistry,
School of Medicine, East Carolina University, Greenville, North Carolina 27858, and ¶Diabetes and Metabolism Unit,
Boston Medical Center, Boston, Massachusetts 02118
Uncoupling protein 3 (UCP3) is a member of the mito-
chondrial anion carrier superfamily. Based upon its
high homology with UCP1 and its restricted tissue dis-
tribution to skeletal muscle and brown adipose tissue,
UCP3 has been suggested to play important roles in
regulating energy expenditure, body weight, and ther-
moregulation. Other postulated roles for UCP3 include
regulation of fatty acid metabolism, adaptive responses
to acute exercise and starvation, and prevention of re-
active oxygen species (ROS) formation. To address these
questions, we have generated mice lacking UCP3 (UCP3
knockout (KO) mice). Here, we provide evidence that
skeletal muscle mitochondria lacking UCP3 are more
coupled (i.e. increased state 3/state 4 ratio), indicating
that UCP3 has uncoupling activity. In addition, produc-
tion of ROS is increased in mitochondria lacking UCP3.
This study demonstrates that UCP3 has uncoupling ac-
tivity and that its absence may lead to increased produc-
tion of ROS. Despite these effects on mitochondrial func-
tion, UCP3 does not seem to be required for body weight
regulation, exercise tolerance, fatty acid oxidation, or
cold-induced thermogenesis. The absence of such phe-
notypes in UCP3 KO mice could not be attributed to
up-regulation of other UCP mRNAs. However, alterna-
tive compensatory mechanisms cannot be excluded. The
consequence of increased mitochondrial coupling in
UCP3 KO mice on metabolism and the possible role of
yet unidentified compensatory mechanisms, remains to
be determined.
Uncoupling protein 3 (UCP3)1 (1–3) is a member of the
mitochondrial anion carrier superfamily with high homology
(57%) to UCP1, a well characterized uncoupling protein (4, 5).
UCP3 together with UCP1, UCP2 (6, 7), and possibly BMCP1
(brain mitochondrial carrier protein) (8) and UCP4 (9), form a
family of uncoupling proteins located in the inner mitochon-
drial membrane. The evidence supporting the uncoupling ac-
tivity of these proteins comes from studies where UCPs have
been heterologously expressed in yeast or reconstituted into
proteoliposomes. The expression of UCP2 and -3 decreases the
mitochondrial membrane potential, as assessed by uptake of
fluorescent membrane potential-sensitive dyes in whole yeast.
They also increase state 4 respiration in isolated mitochondria,
which serves as an indicator of inner membrane proton leak (3,
6, 10). More recently, reconstitution of UCPs into liposomes has
shown that UCP2 and UCP3, like UCP1, mediate proton trans-
port across bilipid layers (11).
It is well established that UCP1 is exclusively expressed in
brown fat, where it plays a key role in facultative thermogen-
esis in rodents. Although there is controversy about the molec-
ular mechanisms involved (12–16), it is clear that activated
UCP1 catalyzes a proton leak across the mitochondrial inner
membrane leading to thermogenesis. The activity of UCP1 is
highly regulated, facilitated by fatty acids and inhibited by
purine ribose di- and trinucleotides (ATP, ADP, GTP, GDP)
(17). UCP1 is also highly regulated at the transcriptional level
(18) by catecholamines, thyroid hormone, retinoids, and
thiazolidinediones.
The characterization of the new uncoupling proteins (UCP2,
UCP3, BMCP1, and UCP4) is in its early phases. UCP2 and
UCP3 are of particular interest because they share the highest
homology with UCP1 (57%) and are expressed in tissues that
may be important for energy expenditure (see below). The
tissue distribution of UCP1, UCP2, and UCP3 is markedly
different. UCP2 is widely distributed (6, 7), whereas UCP3
expression is restricted to skeletal muscle and brown fat (1–3).
It is well established that brown adipose tissue is an important
tissue for thermogenesis in rodents. However, in large mam-
mals in which brown fat is less common, skeletal muscle may
be more important for thermogenesis (19). Thus, based upon
the high homology with UCP1 and its expression in skeletal
muscle, UCP3 has been suggested to play an important role in
regulating energy expenditure, thereby influencing body
weight regulation (1–3, 20).
UCP3, like UCP1, is highly regulated at the transcriptional
level. Factors such as fatty acids (21–23), diet (24), exercise (25,
26), and fasting (27) markedly induce UCP3 expression in
skeletal muscle. The induction of UCP3 during starvation, at a
time when energy expenditure is decreased (28), does not sup-
port a primary role for UCP3 in energy dissipation. However,
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data showing increases in circulating fatty acid levels associ-
ated with starvation, together with several findings linking
UCP3 mRNA levels to fatty acid metabolism, suggest that
UCP3 could be required for fatty acid metabolism. Thus, it is
conceivable that UCP3 could facilitate the oxidation of fatty
acids (29).
As is true for UCP1, it is likely that UCP3 activity is modu-
lated by allosteric regulators. Based upon studies employing
reconstituted proteoliposomes, it has been suggested that fatty
acids are required for the uncoupling activity of UCP2 and
UCP3 (11) and that UCP2 and UCP3 activities are inhibited by
purine nucleotides. However, in contrast to UCP1, much higher
concentrations of purine nucleotides are required for inhibi-
tion, and the maximal degree of inhibition is significantly less
(11).
Other strategies have been used to clarify the function of
UCP3 in humans. Using a genetic approach, linkage analysis
studies suggest that UCP2 and UCP3 may influence resting
metabolic rate (30). However, association studies indicate that
variants of UCP2/3 are unlikely to contribute to the develop-
ment of obesity (31). Of note, association studies in African-
Americans report the existence of a mutation of the splice
donor junction at exon 6 that results in exclusive production of
UCP3S (29, 32) a truncated version of UCP3 lacking the last 37
C-terminal residues. Argyropulos et al. (29) find that individ-
uals heterozygous for this mutation showed reduced fatty acid
oxidation and increased respiratory quotients (29). In contrast,
a recent study including individuals homozygous for this mu-
tation have not found abnormalities in the respiratory quotient
(32).
It has also been proposed that UCP3 could prevent the for-
mation of oxygen-free radicals in skeletal muscle. This hypoth-
esis is based upon the observation that mitochondrial mem-
brane potential regulates the production of reactive oxygen
species (ROS) (33–37). According to this hypothesis, mild mi-
tochondrial uncoupling could markedly decrease superoxide
production by decreasing the mitochondrial membrane poten-
tial below a critical level. Thus, one of the functions of UCP3
could be to prevent the transmembrane electrochemical gradi-
ent from rising above a threshold critical for ROS formation
(33, 35).
In summary, the information available about the physiolog-
ical role of UCP3 is still controversial and incomplete. In the
present study, we attempt to address these questions by using
homologous recombination to create gene knockout mice lack-
ing UCP3.
EXPERIMENTAL PROCEDURES
Targeting Construct and Embryonic Stem Cell Culture (Fig. 1)
Two UCP3 genomic clones were obtained after PCR screening of a P1
C129/SvJ genomic library (Genome System). Both clones were mapped
using Southern blot analysis and end-labeled oligonucleotide probes
designed according to mouse UCP3 cDNA sequence (GenBank™ acces-
sion number AF053352). A replacement targeting vector was prepared
in which a segment of the UCP3 gene between exons 2 and 3, including
the start codon, was removed and replaced with a PGK-NEO-poly(A)
expression cassette (38). The targeting plasmid was linearized with
NotI and electroporated into J1 embryonic stem cells provided by E. Li,
A. Sharp, and R. Jaenisch (39). Selection with G418 was done as
described (38). Drug-resistant clones were isolated and expanded fol-
lowed by genomic DNA extraction for Southern blot analysis (Fig. 1).
Three targeted clones were injected into C57B1/6 embryos at the blas-
tocyst stage. Chimeric offspring were mated with C57B1/6 mice. Germ-
line transmission of the mutant allele was determined by Southern
analysis of mouse tail genomic DNA. Three lines of mice carrying the
disrupted UCP3 were generated.
PCR Analysis
Genotyping was performed by mutiplex PCR. Specific primers used
to detect the KO allele were sense 59-CCT CCA CTC ATG ATC TAT
AGA TC-39, located in the neo cassette, and antisense 59-ACC CTC TGT
CGC CAC CAT AGT CA-39, located in the UCP3 coding sequence. This
set of primers amplified a 300-bp PCR product. Primers used to detect
the wild type allele were sense 59-GCA CTG CGG CCT GTT TTG-39 and
antisense 59-ACC CTC TGT CGC CAC CAT AGT CA-39. This set of
primers amplified a 600-bp PCR product. Standard protocols were used
for PCR.
Animal Care
Animals were housed four per cage in a temperature-controlled room
with a 12-h light/dark cycle. Food and water were available ad libitum
unless noted. All experiments were conducted in accordance with the
National Institutes of Health (NIH) Guide for the Care and Use of
Laboratory Animals.
Northern, Ribonuclease Protection, and Western Blot Analysis
Nucleic Acids—Isolation of nucleic acids (RNA, DNA) and Southern,
Northern, and Ribonuclease protection assays were carried out as de-
scribed previously (40, 41). Most of the probes were PCR-amplified
using specific primers listed in Table I. A full-length rat UCP1 cDNA
including the whole coding sequence was used as a probe. Isotopic
bands were visualized by autoradiography and quantitated by Phos-
phoImager analysis using ImageQuant software (Molecular Dynamics,
Sunnvale, CA).
Antibodies—Rabbit polyclonal antibody against mouse cytochrome c
was purchased from Santa Cruz Biotechnology, Santa Cruz, CA (SC-
7159). Mouse UCP3 antibody was obtained after rabbit immunization
against a peptide (MIRLGTGGERKYRGTMDAYRC), corresponding to
mouse and rat UCP3 amino acids 147–166 encoded by exon 4 (Covance
Research Products, Denver, PA). Antisera was affinity-purified on a
peptide column generated from the respective peptide coupled to a
Sulfo-Link column (Pierce). UCP3 antibody was eluted with 0.1 M
glycine, pH 2.5, and neutralized with 1 M Tris, pH 10.
SDS-Polyacrylamide Gel Electrophoresis Analysis and Immunoblot-
ting—Western blot analyses were performed on isolated skeletal muscle
FIG. 1. The mouse UCP3 gene, targeting vector, and Southern
blot detection scheme. Shown is a partial restriction enzyme map of
the mouse UCP3 gene, the UCP3 KO targeting construct, and the
predicted structure of the recombinant allele. The empirically deter-
mined map is consistent with a previously reported genomic map (24).
The targeting construct contains approximately 8 kilobases (kb) of
homologous mouse UCP3 genomic DNA, with 4 kilobases located 59 and
4 kilobases located 39 of the PGK-NEO-poly(A) cassette (61). The PGK-
NEO-poly(A) cassette replaces approximately 700 bp of mouse UCP3
genomic sequence between restriction sites SmaI (exon 2) and SacII
(exon 3). The Southern blot probe is located outside the targeting
construct sequence. To detect targeted clones, genomic DNA was di-
gested with BglII. Filled boxes refer to exons corresponding to coding
sequence, the locations of which have previously been published (24).
The arrow refers to the orientation of transcription of the PGK-NEO
cassette.
Uncoupling Protein 3 Gene Knockout Mice 16259
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mitochondria (isolation of mitochondria describe below). Western blot
analysis was performed as described previously (41).
Mitochondrial Oxygen Consumption
Mitochondria Isolation—Mitochondria were isolated from skeletal
muscle of wild type (n 5 15) and UCP3 KO mice (n 5 15). Tissue was
ground and homogenized in 10–20 ml of cold buffer (250 mM sucrose, 10
mM Hepes, 0.5 mM EDTA, pH 7.2 with KOH, 0.1% bovine serum albu-
min) and kept on ice. Homogenate was centrifuged at 600 3 g for 5 min.
The pellet was discarded, and the supernatant was centrifuged at
8000 3 g for 10 min. The mitochondrial pellet was washed twice and
finally resuspended in buffer without bovine serum albumin. The mi-
tochondria were then used for immunoblotting, polarography, and as-
says of aconitase activity.
Polarography—Mitochondrial respiration was measured in a Clark-
type oxygen electrode at 37 °C using the following incubation condi-
tions: 250 mM sucrose, 10 mM Hepes, pH 7.2, 5 mM KH2PO4/K2HPO4,
0.5 mM EDTA, 5 mM malate, 10 mM glutamate, and approximately 0.5
mg of mitochondrial protein/ml. The data were channeled into an A/D
converter and recorded on a Pentium-based PC using the DataShuttle
A/D converter and the Quicklog software package. The oxygen electrode
was calibrated with experimental buffer saturated with room air as-
suming a solubility coefficient of 199 nmol O2/ml at 30 °C.
Determination of ATP, ADP, and Phosphocreatine
Concentrations in Skeletal Muscle
Perchloric acid extracts of frozen muscle were prepared as follows.
100–200 mg of skeletal muscle (gastrocnemius) tissue were homoge-
nized using a Polytron in 1.0 ml of 6% perchloric acid on ice. The
samples were centrifuged for 1 min at 8000 3 g. 600 ml of the super-
natant were removed and neutralized by adding 300 ml of 0.4 M trieth-
anolamine HCl, 1.6 M K2CO3. ADP, ATP, and phosphocreatine were
measured enzymatically as described previously by Jaworek et al. (42).
Oxygen Consumption (VO2) and Respiratory
Exchange Ratio (RER)
Oxygen consumption and respiratory exchange ratio were measured
in 10-week-old UCP3 knockout and wild type mice in basal and fasted
conditions (5 mice per group and treatment) using the OXYMAX Sys-
tem 4.93 (Columbus Instruments, Columbus, OH) and conditions of a
settling time of 100 s, measuring time of 50 s, and room air as a
reference. Animals were placed individually in 4 0.3-liter chambers.
Results are expressed as ml/kg/min. To correct for body size, results are
also expressed as ml/kg2/3/min.
Influence of UCP3 on Body Weight,
Food Intake, and Thermogenesis
Body Weight—UCP3 KO and wild type mice body weights were
recorded weekly for 18–22 weeks (n 5 9–12 per group and treatment).
The effect of chow diet (Richmond Stenolard #5008) and a high fat diet
(Research Diets Inc #D12451) on the evolution of body weight was
assessed. Chow diet 5 10% fat, 70% carbohydrate, and 20% protein (as
percent o total calories); high fat diet 5 45% fat, 35% carbohydrate, and
20% protein (as % of total calories). Both genders and the three possible
genotypes (1/1, 1/2, 2/2) were studied.
Muscle Weights—Tibialis anterior, soleus, and heart were carefully
dissected and weighed. To correct for differences in muscle weight due
to differences in age and body weight, results are expressed as absolute
weight and as the ratio muscle weight (g)/total body weight.
Carcass Analysis Was Performed in Male Animals—Specifically, we
studied wild type mice on chow (n 5 9) and high fat diets (n 5 8) and
UCP3 KO mice on chow (n 5 11) and high fat diets (n 5 9). Total body
lipid content was assessed using alcoholic potassium hydroxide diges-
tion with saponification of all fats, neutralization, and then enzymatic
determination of glycerol as described previously (44). Triglyceride
content is expressed as g/carcass and as percentage of total body weight.
Food Intake—Food intake was measured in 10-week-old UCP3 KO
female (n 5 7), UCP3 KO male (n 5 5), control female (n 5 8), and
control male (n 5 8) mice for 3 weeks after a 1-week period of adapta-
tion. Animals were housed individually and had free access to water.
Food was weighed weekly, and the differences were assumed to repre-
sent grams of food eaten per week. Data are presented as g/day. To
correct for body size, results are also expressed as g/day/body weight2/3.
The cages were inspected for food spillage, and none was noted.
Thermogenesis—Rectal temperature was assessed using a rectal
probe (Yellow Spring Instruments Co.) in control (C) and UCP3 KO
mice under the following situations: (a) fed state (C, n 5 9; KO, n 5 9)
and (b) following 1, 4, and 24 h of cold exposure (C, n 5 5; KO, n 5 5).
Effects of Exhaustive Exercise
Animals—Thirty-two mice (5–9 months old) were matched for age
and randomly divided into four groups as follows: 1) wild type-seden-
tary; 2) wild type-exercised; 3) UCP3 KO-sedentary; 4) UCP3 KO-
exercised. Animals were given water and fed ad libitum and were
maintained on a 12-h light/dark cycle.
Exercise Protocol—On the day before the exercise test, mice (wild
type (WT) 5 9, KO 5 9) were accommodated to the treadmill apparatus
and run twice for 2 h with a 30-min rest period between each running
protocol. Within each 2-h running trial, the mice ran to physical ex-
haustion according to the following protocol: mice were accommodated
to the treadmill apparatus by running at 10 meters/min for 10 min at
0% grade. Afterward, the treadmill speed was increased by 5 meters/
min every 30 min so that the animals were running at a final speed of
30 meters/min for the final half of the 2-h protocol. The percentage
grade of the treadmill was increased at 60 (3%), 90 (6%), and 105 min
(9%). The animals continued to run at 30 meters/min up the 9% grade
until they became physically exhausted (inability to avoid a shock
device located in the back of the running stall) or the test was termi-
nated at 2 h. The time (seconds) to exhaustion was recorded, and
exhaustion was verified by the absence of a righting reflex (inability of
the animal to right itself when placed on its back). Because UCP3
activity might be bioenergetically necessary to recover from vigorous
exercise challenge, the mice rested for 30 min, and the protocol was
repeated to evaluate their exercise capacity following recovery. The
following day, the same 2 h running protocol to exhaustion was em-
ployed, and assessment of skeletal muscle carbohydrate and lipid me-
tabolism was made immediately post-exercise.
Muscle Glucose and Fatty Acid Oxidation
Food was withdrawn from both sedentary and exercised animals 3 h
before the exercise test. Immediately after exercise, animals were anes-
thetized (ketamine/zylazine, 100 mg/10 mg/kg), and soleus and extensor
digitorum longus muscles were excised, cleaned of adipose and connec-
tive tissue, and transferred to a 24-well tissue culture plate in a shaking
bath at 29 °C. One soleus and one extensor digitorum longus were used
to measure fatty acid oxidation, and contralateral muscles were used to
determine glucose oxidation. Muscles were incubated as described pre-
viously (45) in 1.0 ml of modified Krebs-Henseleit buffer continuously
gassed with 95% O2, 5% CO2. After 15 min at 29 °C, muscles were
placed in fresh modified Krebs-Henseleit buffer containing 1.0 mmol/
liter sodium oleate, 1.0 mmol/liter carnitine, and 1% bovine serum
albumin and pre-incubated for an additional 20 min at 37 °C. Muscles
were then transferred to identical media but with either [U-14C]glucose
(1.0 mCi/ml) or [1-14C]oleate (1.0 mCi/ml) and incubated 90 min at
37 °C. Afterward, the CO2 produced by muscle was driven from the
media by adding 100 ml of 70% perchloric acid to each well. [14C]CO2
was trapped onto NaOH- saturated Whatman No. 3 filter paper, and
oxidation rates were quantified as described previously (45).
Blood Glucose and Insulin Determinations
Blood glucose and insulin determinations were obtained after an
overnight fast and in fed animals (obtained between 8 a.m. and noon)
using a glucometer (One Touch, Lifescan, Milpitas, CA) and an enzyme-
linked immunosorbent assay (Crystal Chem Inc. Chicago, IL) with rat
insulin as a standard. Free fatty acids were measured using a commer-
cially available kit (Wako NEFA C kit, Wako Chemicals, Richmond,
TABLE I
List of primers for Northern and RNase protection assay probes
mUCP3 (10–300 bp)
59-GCT GCT ACC TAA TGG AGT GG-39
59-GTT CTC CCC TTG GAT CTG CAG-39
mUCP3 (581–775 bp)
59-AGG TCC GAT TTC AAG CCA TG-39
59-CAG GTG AGA CTC CAG CAA-39
mUCP3 (740–1054 bp)
59-GAT GGT GAC CTA CGA CAT CAT CAA GGA-39
59-AGG CCC TCT TCA GTT GCT CAT A-39
mUCP3 (1015–1190 bp)
59-CAT ATG AGC AAC TGA AGA GG-39
39-CGT GTC AGC AGC AGT GCA GGG-39
mUCP2 (709–904 bp)
59-CTG GTC GCC GGC CTG CAG CGC-39
59-GGG CAC CTG TGG TGC TAC CTG-39
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VA). Triglycerides (#337), b-hydroxybutyrate (#310-UV), creatine phos-
phokinase (#520), lactate (#735-10), and blood urea nitrogen (#535)
were measured using kits from Sigma.
Oxygen Free Radical Studies in Skeletal Muscle Mitochondria
Measurement of Mitochondrial Superoxide Anion Production by Lu-
cigenin-derived Chemiluminescence (LDCL) (46)—LDCL was measured
at 25 °C using a Berthold luminometer. The incubation conditions were
as follows: 70 mM sucrose, 220 mM mannitol, 2 mM Hepes, pH 7.4, 2.5
mM potassium phosphate, 0.5 mM EDTA, 5 mM malate, 10 mM gluta-
mate, 20 mM lucigenin. After recording the background LDCL for 4 min,
the assay was initiated by the addition of 0.1 mg/ml mitochondria.
LDCL was recorded for 10 min in 2-min intervals, and the data were
expressed as the integrated area under the curve. The effects of a
superoxide dismutase mimetic (47) (SC52608, Monsanto Corporate Re-
search, St. Louis, MO) and an uncoupler, 1 mM carbonyl cyanide p-
(trifluoromethoxy) phenylhydrazone (FCCP), on lucigenin chemilumi-
nescence were assessed as controls.
Mitochondrial Aconitase Activity in Isolated Mitochondria Was
Measured Following the Protocol of Hausladen and Fridovich (48)—
Mitochondria were isolated, 40–60 mg of mitochondria were incubated
in 1% Triton X-100, and the extract was resuspended in buffer contain-
ing 50 mM Tris-Cl pH 7.4, 30 mM sodium citrate, 0.6 mM MnCl2, 0.2 mM
NADP, 1–2 units of isocitrate dehydrogenase (Sigma I-2516, derived
from porcine heart). After adding the mitochondrial extract, the absorb-
ance at 340 nm increased at a rate corresponding to aconitase activity.
The level of aconitase activity measured in the mitochondrial extract
equals active aconitase (basal level). Aconitase inhibited by ROS in vivo
was reactivated so that total activity could be measured by incubating
mitochondrial extracts with 0.5 M dithiothreitol, 20 mM Na2S, and 20
mM ferrous ammonium sulfate. Aconitase activity, measured after re-
activation, equals the total aconitase activity. Results are expressed as
the basal/total aconitase activity ratio (48).
Statistical Analysis
Statistical analysis was performed using StatView 4.0 (Abacus Con-
cept, Berkeley, CA). Results are presented as the mean 6 S.E. Unpaired
Student’s t test and analysis of variance were performed as specified in
figure and table legends (a p value 0.05 was used for significance).
RESULTS
UCP3 KO Mice Lack UCP3 mRNA and Protein—We devel-
oped an RNase protection assay that allows quantitation of
mRNAs encoding mouse UCP3. We confirmed that the mRNA
sequence corresponding to exons 2–6 was absent in skeletal
muscle (Fig. 2A) and brown adipose tissue of UCP3 KO mice
(data not shown). Western blotting analysis using an antibody
raised against a peptide corresponding to the sequence encoded
by exon 4 of UCP3 identified a band of the expected size (34
kDa) in the WT skeletal muscle mitochondria (Fig. 2B). This
band was absent in UCP3 KO skeletal muscle mitochondria.
UCP3 KO Mice Do Not Have Compensatory Up-regulation of
UCP1, UCP2, and BMCP1—UCP1 and UCP2 mRNAs were
quantified by Northern blot and RNase protection assay anal-
ysis, respectively, using total RNA isolated from interscapular
brown adipose tissue and gastrocnemius muscle. UCP2 mRNA
in skeletal muscle (WT 239 6 19 versus KO 258 6 12 arbitrary
units), n 5 6) (Fig. 2D) and UCP1 mRNA in brown adipose
tissue (WT 265 6 24 versus KO 283 6 35 arbitrary units, n 5
6) were not up-regulated in UCP3 KO mice. UCP2 was not
up-regulated in UCP3 KO brown adipose tissue (WT 372 6 25
versus KO 349 6 31, n 5 6; not shown), and UCP1 mRNA was
not detected in skeletal muscle (data not shown). Expression of
BMCP1 (8) mRNA in skeletal muscle was assessed but was
barely detectable in control mice and was not up-regulated in
UCP3 KO animals (results not shown).
Respiration in UCP3 KO Skeletal Muscle Mitochondria—Respi-
ration was measured in isolated skeletal muscle mitochondria from
control and UCP3 KO male mice. An average of 15 independent
experiments with at least two repeats per experiment were per-
formed. As is shown in Fig. 3, UCP3 KO mice had an increased
state 3/state 4 ratio (*, p 5 0.002), which was due to a decrease in
state 4 respiration (*, p 5 0.01). State 3 respiration was similar in
WT and UCP3 KO mitochondria. These results indicate that a lack
of UCP3 in skeletal muscle mitochondria increases the coupling of
mitochondrial respiration to ADP availability, establishing for the
first time that endogenous levels of UCP3 uncouple mammalian
mitochondria.
Skeletal Muscle Weight, ATP, ADP, and Phosphocreatine
Content—We investigated whether the lack of UCP3 resulted
in any changes in skeletal muscle weights. As shown in Table
II, the weights of several muscles (tibialis anterior, soleus, and
heart) were similar in WT and UCP3 KO mice. Also, no statis-
tically significant differences in the absolute values of ATP,
ADP, or creatine phosphate were observed in skeletal muscle of
UCP3 KO mice. However, ADP tended to be lower, and the
ATP/ADP ratio tended to be higher in UCP3 KO mice
(Table II).
Effect of UCP3 Deficiency on Body Weight Regulation, Total
Body Triglyceride Content, and Food Intake—We studied
whether the lack of UCP3 resulted in the development of obe-
sity or predisposed to diet-induced obesity. Male and female
UCP3 KO, UCP3 heterozygous, and wild type mice were
weighed at 1-week intervals for 18–22 weeks (Fig. 4; data not
shown for heterozygotes). The effects of two diets (chow and
high fat diet) on body weight were studied. On the chow diet, no
statistical differences in body weight were observed between
groups. Male UCP3 KO mice fed a high fat diet tended to weigh
more than wild type mice but the difference, probably due to
body weight variability, did not reach statistical significance.
Female mice of all genotypes fed a high fat diet were similar in
body weight. Carcass analysis (g of triglyceride per carcass and
percentage of fat per carcass) of chow and high fat fed male
FIG. 2. Expression of UCP1, UCP2, and UCP3. A, UCP3 RNase
protection assay. UCP3 and cyclophilin mRNA levels were determined
using 10 mg of skeletal muscle RNA as described under “Experimental
Procedures.” The UCP3 mouse probe corresponds to exons 6–7, and the
expected protected band was 314 bp. Genotypes (WT and KO) were
previously determined by PCR of tail genomic DNA. B, immunoblotting
with UCP3 mouse polyclonal antibody. Samples correspond to proteins
(50 mg) derived from isolated skeletal muscle mitochondria of UCP3 KO
and WT mice. Proteins were separated by SDS-polyacrylamide gel
electrophoresis (12–15%) followed by western immunoblotting. UCP3 is
a 34-kDa protein. C, immunoblotting with cytochrome c antibody (14
kDa) was used as an internal control. D, UCP2 RNase protection assay.
UCP2 mRNA was measured using 10 mg of total RNA isolated from
gastrocnemius muscle of 8-week-old mice. Cyclophilin was used as an
internal control. E, UCP1 mRNA Northern blot analysis. UCP1 mRNA
levels were determined by Northern blot analysis using 20 mg of total
RNA isolated from interscapular brown adipose tissue. Northern blot
and RNase protection assay protocols were performed and analyzed
using a PhosphoImager as described under “Experimental Procedures.”
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mice revealed no statistically significant effect of genotype on
total body lipid content (Table III). Total food intake was meas-
ured in a different set of 8-week-old mice that were fed a chow
diet for 3 weeks. No differences in food intake (g/day) were
observed between UCP3 KO and control mice.
The Lack of UCP3 Does Not Modify the Respiratory Exchange
Ratio (RER) and Rates of Oxygen Consumption (VO2) (Table
III)—Mice in the fed and fasted (24 h) state were studied. As
expected, fasting was associated with a decrease in VO2 (*, p ,
0.05) due to a decrease in energy expenditure (49), and in RER
(p , 0.001), due to preferential use of lipids as fuel. However,
no differences were observed in O2 consumption and RER be-
tween control and UCP3 KO mice, either in the fed or fasted
state.
The Lack of UCP3 Does Not Affect Maintenance of Body
Temperature during Cold Exposure (Table III)—In this study
we addressed the potential role of UCP3 in thermoregulation.
Rectal temperature was assessed in WT and UCP3 KO mice in
the fed state (n 5 9 per group). No statistical differences be-
tween WT and KO mice were observed. To study the thermo-
genic adaptation of UCP3 KO mice to cold environment, mice
were housed at 4 °C, and their rectal temperatures were meas-
ured after 1, 4, and 24 h. No differences were observed between
WT and KO mice at any time point.
Plasma Free Fatty Acids and Other Blood Parameters (Table
IV)—As an initial approach to evaluate the potential role of
UCP3 in fatty acid homeostasis, plasma free fatty acids levels
were measured in three specific situations: (a) in newborn mice
(4–6 days old) that depend exclusively on milk ingestion (rich
in fatty acids); (b) in young (6 weeks old) mice in the fed (chow
diet) and fasted state (36 h); and (c) in 18–24-week old mice in
the fed (on chow and high fat diets) and fasted states (36 h after
a chow diet). Free fatty acids tended to increase in the 18–24-
week-old UCP3 KO mice. This difference was statistically sig-
nificant in the 18–24-week-old group challenged with a high fat
diet (Table IV). No statistical differences in plasma fatty acid
levels were observed either in newborn mice or 6-week-old mice
in the fed or fasted state. Other blood parameters such as
triglycerides, b-hydroxybutyrate, creatine kinase, lactate, glu-
FIG. 3. Mitochondrial oxygen con-
sumption. O2 consumption was meas-
ured in isolated skeletal muscle mito-
chondria from wild type and UCP3 KO
male mice as described under “Experi-
mental Procedures.” Data represent an
average of 15 independent experiments.
Each separate experiment was repeated
at least twice. Unpaired Student’s t test:
*, p 5 0.01; **, p 5 0.002 versus wild type.
TABLE II
Measurements in skeletal muscle
Unpaired Student’s t test was used for the statistical analysis. No significant differences were observed. Het, heterozygote; TA, tibiales anterior;
SO, soleus. Results are expressed as absolute weight (abs) (mg, mean 6 S.E.) and corrected (abs 3 1000/total body weight).
Gender Diet Genotype
Weight of muscles
TA
(abs/corrected)
SO
(abs/corrected)
Heart
(abs/corrected)
Male Chow WT 92 6 3/2.7 (n 5 11) 19 6 1/0.54 (n 5 10) 155 6 8/ 4.8 (n 5 8)
Male Chow KO 93 6 3/2.6 (n 5 16) 18 6 1/0.51 (n 5 16) 161 6 10/4.9 (n 5 11)
Male HFD WT 80 6 5/1.9 (n 5 9 ) 19 6 1/0.46 (n 5 9 ) 156 6 12/4.1 (n 5 4 )
Male HFD KO 98 6 3/1.9 (n 5 11) 20 6 1/0.40 (n 5 11) 184 6 10/3.6 (n 5 5 )
ATP, ADP, and creatine phosphate in skeletal muscle
WT KO
ATP (mmol/g tissue) 5.13 6 0.39 5.10 6 0.59 n 5 5
ADP (mmol/g tissue) 0.94 6 0.15 0.67 6 0.15 n 5 5
ATP/ADP 5.76 6 0.54 7.53 6 0.34 n 5 5
Creatine phosphate
(mmol/g tissue)
8.80 6 0.30 8.70 6 0.60 n 5 5
FIG. 4. Growth curves. Diet study. UCP3 KO (kochow) and wild
type (wtchow) controls were weighed at 1-week intervals for 18–22
weeks. The effect of two diets (chow and high fat diet) was assessed. All
three genotypes (1/1, 1/2, 2/2) were studied; however, only growth
curves from WT and KO mice are shown. The number of animals used
in this experiment was 9–12 animals per group. Data are the mean 6
S.E. Factorial and repeated analysis of variance were performed, and no
statistically significant differences were detected.
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cose, and insulin were similar in WT and KO mice (Table IV).
Effects of Exhaustive Exercise on Physical Performance and
on Skeletal Muscle Glucose and Fatty Acid Oxidation—Exer-
cise is associated with a dramatic increase in skeletal muscle
ATP utilization. To support increased ATP requirements, ATP
synthesis must be stimulated accordingly. To address the role
of UCP3 in this response, mice were challenged with a protocol
of acute exercise. This protocol included a progressive increase
in the speed and uphill gradient of the treadmill for 2 h or until
mice were exhausted. To study the recovery capacity post-
exercise, a similar protocol was repeated after 30 min of rest.
Two animals from each group failed to complete the initial part
of the test, whereas the remaining mice ran for the required
2 h. None of the conditions tested revealed any alteration in the
physical performance of UCP3 KO mice. Similarly, no differ-
ences were observed in their recovery capacity post-exercise.
We investigated whether skeletal muscle carbohydrate and
lipid metabolism were affected during rest and exhaustive ex-
ercise. To address this, fatty acid and glucose oxidation were
measured in soleus and extensor digitorum longus muscles
from sedentary and exercised mice. No differences in fatty acid
or glucose oxidation were observed between WT and KO mice
(Table V). With exercise, there was a trend for fatty acid oxi-
dation to decrease and for glucose oxidation to increase in both
WT and KO mice.
Reactive Oxygen Species Production by UCP3 KO Skeletal
Muscle Mitochondria—We explored the possibility that the
lack of UCP3 resulted in increased production of ROS. We first
investigated whether skeletal muscle mitochondria lacking
UCP3 produced more superoxide anions. Isolated skeletal mus-
cle mitochondria from 6–8-week-old UCP3 KO and WT mice
were used to measure LDCL in the absence of ADP using
glutamate and malate as respiratory substrates. To confirm the
specificity of the LDCL assay, we added a superoxide dis-
mutase mimetic compound (SC52608), an uncoupler (FCCP),
and ADP. SC52608 scavenged oxygen free radicals, whereas
FCCP and ADP decreased mitochondrial membrane potential,
FCCP by its cycling protonophore activity and ADP by stimu-
lating ATP synthase. The LDCL-integrated area was inhibited
by 50% with ADP, by 87% with SC52608, and by 100% with
FCCP (Fig. 5A). Finally, using a yeast heterologous system
expressing UCP1, we found that inhibition of UCP1 uncoupling
activity with GDP resulted in an increase of lucigenin chemi-
luminescence (Fig. 5B).
The LDCL integrated area of isolated skeletal muscle mito-
chondria from UCP3 KO mice was 58 6 10% higher compared
with control mitochondria (Fig. 5A). These data suggest that
superoxide anion production is increased in skeletal muscle
mitochondria from UCP3 KO mice.
We then measured mitochondrial aconitase activity as an in
vivo indicator of ROS production. Mitochondrial aconitase ac-
tivity was reduced by 20% (p , 0.01) in isolated muscle mito-
chondria from 6–8-week-old UCP3 KO mice (Fig. 5C). No dif-
ferences in aconitase activity were observed between
mitochondria isolated from the liver of UCP3 KO and WT mice
(data not shown). No differences in total aconitase activity after
reactivation were observed, indicating that UCP3 KO and WT
skeletal muscle mitochondria contained similar amounts of
total aconitase. These observations indicate that UCP3 KO
skeletal muscle mitochondria overproduce ROS in vivo.
DISCUSSION
Uncoupling protein 3 is a member of the mitochondrial anion
carrier superfamily. Based upon its high homology with UCP1
and its restricted tissue distribution to skeletal muscle and
brown adipose tissue, it has been suggested that this protein
could play important roles in regulating energy expenditure,
body weight homeostasis, and thermoregulation. Identification
of various physiologic states in which UCP3 mRNA levels are
increased have led to the proposal that UCP3 may play roles in
fatty acid metabolism and adaptive responses to acute exercise
and starvation. It has also been suggested that the uncoupling
activity of this protein may prevent the production of oxygen
reactive species in mitochondria (35). To address these issues,
TABLE III
Measurements in the whole animal
NS, not statistically significant between genotype (WT vs. KO); Tgl, triglycerides; bw, body weight. Unpaired Student’s t test and analysis of
variance post hoc test were used for statistical analysis.
WT KO
Food intake (g/day)
Males 4.6 6 0.08 n 5 7 4.7 6 0.14 n 5 5 NS
Females 4.1 6 0.24 n 5 8 4.0 6 0.24 n 5 8 NS
Food intake
(g/day/bw2/3)
Males 0.58 6 0.04 n 5 7 0.55 6 0.18 n 5 5 NS
Females 0.52 6 0.02 n 5 8 0.53 6 0.14 n 5 8 NS
Carcass (g Tgl/carcass)
Chow 7.2 6 1.2 n 5 9 6.9 6 1.0 n 5 11 NS
HFD 10.2 6 0.9 n 5 8 9.1 6 1.5 n 5 9 NS
Carcass (% fat)
Chow 23.9 6 4.1 n 5 9 22.7 6 3.4 n 5 11 NS
HFD 26.8 6 2.3 n 5 8 20.1 6 3.3 n 5 9 NS
Temperature (° C)
Basal 35.3 6 0.3 n 5 10 35.6 6 0.3 n 5 10 NS
1-h cold 33.5 6 0.5 n 5 5 32.8 6 0.7 n 5 5 NS
4-h cold 33.7 6 0.3 n 5 8 33.1 6 0.4 n 5 8 NS
24-h cold 34.6 6 0.2 n 5 4 34.4 6 0.4 n 5 4 NS
RER
Fed 0.84 6 0.01 n 5 5 0.84 6 0.01 n 5 5 NS
Fast 0.75 6 0.01 n 5 5 0.73 6 0.01 n 5 5 NS
O2 consumption (VO2)
(ml/kg/min)
Fed 37.2 6 3.0 n 5 5 38.0 6 2.4 n 5 5 NS
Fast 30.0 6 1.9 n 5 5 32.0 6 1.2 n 5 5 NS
(ml/kg2/3/min)
Fed 109.9 6 8.2 n 5 5 117.6 6 7.3 n 5 5 NS
Fast 84.1 6 5.6 n 5 5 94.3 6 5.5 n 5 5 NS
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we have generated and characterized the phenotype of mice
lacking UCP3.
UCP3 KO mice appear to be healthy animals. They do not
have gross morphological alterations, and they do not develop
obesity. Their resting energy expenditure and thermoregula-
tion are normal, and they appear to be similar to wild type mice
in their tolerance for exercise. However, our data provide clear
biochemical evidence that respiration in skeletal muscle mito-
chondria lacking UCP3 is abnormal. Indeed, UCP3 KO skeletal
muscle mitochondria are more coupled, as evidenced by an
increased respiratory control ratio (state 3/state 4). This higher
coupling is due to a fall in state 4 respiration, which represents
respiration due to proton leak. This observation is important
because it represents the first clear evidence that UCP3, ex-
pressed at physiological levels in muscle, has proton transport
activity and consequently functions as a genuine uncoupling
protein.
Our results show that the lack of UCP3 is not associated with
obesity. No differences in body weight, triglyceride content, and
food intake were observed. Only UCP3 KO male mice chal-
lenged with high fat diet tended to be heavier (however, this
was not statistically significant). These data indicate that
UCP3 is not required for normal body weight regulation. This
observation may not be completely surprising, since the genetic
disruption of another uncoupling protein, UCP1, did not result
in obesity (50). Since UCP2 mRNA levels are elevated in brown
fat of UCP1 KO mice, it has been suggested that UCP2 might
account for the lack of obesity in these mice. Against this idea
is the observation that up-regulation of UCP2 in UCP1 KO
mice failed to compensate with respect to cold sensitivity (50).
Mice lacking UCP3 are not obese, are not cold sensitive, and
they do not have up-regulation of either UCP2 or UCP1
mRNAs. This suggests that UCP3 may not play an important
role in regulating body weight or adaptive thermogenesis in
response to cold exposure. However, it cannot be excluded that
the lack of UCP3 activity could be compensated through post-
translational activation of UCP2 and/or UCP1 activity or, al-
ternatively, through activation of other unknown futile cycles.
Thus, double and triple UCP knockout mice would be useful
tools to address these questions.
Several earlier studies suggest that free fatty acids induce
the expression of UCP3 in vivo (21, 51) and in vitro (22). These
observations and others (23) suggest that UCP3 may have a
role in fatty acid metabolism, possibly by facilitating the oxi-
dation of fatty acids. However, no statistical differences in
blood fatty acid levels were observed in newborn mice (4 to 6
days post-delivery) and young mice (6 weeks). However, the
study of 18- to 24-week-old animals revealed that UCP3 KO
mice tended to have higher fatty acid levels in blood reaching
statistical significance when challenged with a high fat diet.
These results raise the possibility of an age-related progressive
deterioration of fatty acid homeostasis in UCP3 KO mice. How-
ever, the mechanism for such an effect is unknown.
The analysis of fatty acid and glucose oxidation at rest and
post-exercise did not reveal any differences between WT and
KO skeletal muscle. Although several gene expression studies
(21, 23, 51) and a study in humans (29) point to a role of UCP3
in fatty acid oxidation, our studies in isolated muscles (free
fatty acid oxidation) and in whole animals (RER) indicate that
UCP3 is not required for normal rates of fatty acid oxidation in
mice.
Although UCP3 KO skeletal muscle mitochondria were more
coupled, no changes in whole animal VO2 were observed. Al-
though our system detected the expected changes in VO2 in-
duced by fasting, no differences were observed between control
and UCP3 KO mice in any of the states studied. These results
indicate that either UCP3-uncoupling activity in muscle is not
an important determinant of VO2 in the whole animal or that
other mechanisms are effectively compensating for the lack of
UCP3. Normal fatty acid and glucose oxidation in isolated
muscles together with the normal respiratory exchange ratio
observed in whole animals suggest that UCP3 does not play a
major role in fuel partitioning. But again, it cannot be com-
TABLE V
Fatty acid and glucose oxidation in skeletal muscle
Unpaired Student’s t test was used for statistical analysis. EDL,
extensor digitorum longus.
WT KO
Rate of oleate oxidation in skeletal muscle (nmol/g/h)
Soleus
Sedentary 130 6 26 127 6 30 (n 5 6)
Exercise 131 6 17 132 6 22 (n 5 6)
EDL
Sedentary 156 6 23 146 6 25 (n 5 6)
Exercise 108 6 24 112 6 19 (n 5 6)
Rate of glucose oxidation in skeletal muscle (nmol/g/h)
Soleus
Sedentary 419 6 96 385 6 75 (n 5 6)
Exercise 418 6 57 394 6 39 (n 5 6)
EDL
Sedentary 566 6 103 517 6 117 (n 5 5)
Exercise 651 6 93 601 6 73 (n 5 5)
TABLE IV
Blood determinations
All measurements performed in 8–10-week-old male mice except
where noted. Analysis of variance post hoc test Bonferroni/Dunn was
used for statistical analysis.
WT KO
Triglycerides (mM)
Chow 0.59 6 0.10 n 5 8 0.69 6 0.10 n 5 11
HFD 1.02 6 0.20 n 5 5 0.90 6 0.10 n 5 5
Fast 0.62 6 0.02 n 5 7 0.60 6 0.10 n 5 7
b-Hydroxybutyrate
(mmol/liter)
Fed 260 6 40 n 5 8 270 6 50 n 5 8
Fast 1030 6 150 n 5 5 1270 6 120 n 5 5
Urea (mg/dl)
Chow 13.1 6 4.0 n 5 5 13.9 6 4.0 n 5 5
HFD 9.8 6 1.0 n 5 5 10.5 6 0.5 n 5 5
Creatine kinase
(mmol/min/liter)
Fed 50 6 10 n 5 10 41 6 9 n 5 6
Fast 196 6 34 n 5 9 243 6 35 n 5 7
Lactate (mmol/liter)
Fed 3814 6 720 n 5 9 3993 6 377 n 5 7
Fast 2176 6 301 n 5 5 1998 6 257 n 5 6
Glucose (mg/dl)
Chow 144 6 6 n 5 20 154 6 5 n 5 20
Fast (post-chow) 77 6 4 n 5 9 78 6 4 n 5 10
HFD 218 6 19 n 5 5 195 6 17 n 5 5
Fast (post-HFD) 97 6 11 n 5 5 100 6 18 n 5 5
Insulin (pg/ml)
6–8 weeks
Chow 1319 6 209 n 5 11 795 6 112 n 5 7
Fast 445 6 40 n 5 6 617 6 123 n 5 7
HFD 2907 6 89 n 5 4 3107 6 201 n 5 4
18–22 weeks
Chow 1334 6 428 n 5 5 2767 6 678 n 5 10
Fast 273 6 84 n 5 6 260 6 89 n 5 6
HFD 3325 6 1057 n 5 7 5117 6 1139 n 5 7
Fatty acids (mM)
3–6 days 0.67 6 0.04 n 5 6 0.58 6 0.05 n 5 8
6–8 weeks
Chow 0.46 6 0.04 n 5 10 0.55 6 0.05 n 5 10
Fast 0.95 6 0.06 n 5 9 0.74 6 0.06 n 5 11
18–22 weeks
Chow 0.52 6 0.16 n 5 5 0.74 6 0.16 n 5 10
Fast 0.95 6 0.06 n 5 6 1.13 6 0.12 n 5 6
HFD 0.45 6 0.06 n 5 5 0.87 6 0.08 n 5 8a
a p , 0.05.
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pletely excluded that UCP2 and/or UCP1 or another futile cycle
could be compensating for the deficit of UCP3.
Several gene expression studies suggest that UCP3 could
play an important role in exercise performance (25, 26). How-
ever, our data clearly show that the lack of UCP3 does not alter
physical performance during acute exercise to exhaustion. The
physical performance was also similar during the second round
of exercise, indicating that KO and WT mice have similar
recovery capacities post-exercise. Fatty acid and glucose oxida-
tion after exercise did not reveal any impairment in exercise-
induced alterations in skeletal muscle fuel utilization.
The role of UCP3 in cold exposure-induced thermogenesis
was also studied. It is well established that UCP1 plays an
important role in thermoregulation in rodents (50, 52, 53). Our
data show that UCP3 KO mice exposed to cold have normal
temperature homeostasis, indicating that unlike UCP1, UCP3
is not required for normal thermoregulation in response to cold
exposure.
Several studies suggest that ROS production is a function of
the mitochondrial membrane potential (34, 36, 54). It has been
hypothesized that ROS are produced when the mitochondrial
membrane potential is above a specific threshold. Indeed, ROS
production is increased during state 4 respiration, when the
inner membrane mitochondrial potential is at its peak (33). An
increase in mitochondrial membrane potential slows electron
transport through the respiratory chain, resulting in an in-
crease in the ubiquinone free-radical half-life (33). As a result,
electrons have an increased probability of interacting with
oxygen to form ROS. Thus, mild uncoupling of the mitochon-
dria could be a mechanism to prevent the formation of oxygen
free radicals (35). This mechanism could be important in skel-
etal muscle, given that it accounts for an important fraction of
the total oxygen consumption at rest and that this fraction is
even higher when skeletal muscle switches to maximal activity.
On the other hand, superoxide anions are produced at high
levels during the transition from anaerobiosis (i.e. anaerobic
exercise) to reoxygenation (i.e. post-exercise) (55, 56).
To determine whether the production of ROS was increased
in the UCP3 KO mouse skeletal muscle mitochondria, we used
two independent approaches. The first was an in vitro method
based on LDCL to detect superoxide anion production. Al-
though there has been some concern about the specificity of the
lucigenin assay (57), it has recently been shown that lucigenin
can be used reliably with isolated mitochondria with concen-
trations up to 20 mM (46, 58). To validate this measurement, we
studied LDCL in incubated mitochondria after the addition of a
ROS scavenger, an uncoupler, and ADP, the latter two of which
decrease the mitochondrial proton electrochemical gradient. As
expected, each of these treatments decreased chemilumines-
cence. We also observed that LDCL was increased when UCP1-
expressing yeast mitochondria were incubated with GDP, an
inhibitor of UCP1-mediated uncoupling activity (52). We next
used the LDCL method to assess ROS production in UCP3 KO
skeletal muscle mitochondria. UCP3 KO skeletal muscle mito-
chondria have increased LDCL compared with wild type mito-
chondria. This finding suggests that skeletal muscle mitochon-
dria lacking UCP3 produce more superoxide anions.
As a measure of oxygen free radical production in vivo, we
assessed mitochondrial aconitase activity (57, 59) in skeletal
muscle mitochondria. Aconitase enzymatic activity is inhibited
by ROS and serves as an indicator of ROS production. Mito-
chondrial aconitase activity was decreased by 20–25% in UCP3
KO mice, indicating an increase in ROS production in vivo. As
expected, no difference between WT and KO mice was observed
in liver mitochondria (liver mitochondria do not express UCP3
protein), suggesting that the effect observed in skeletal muscle
was specifically mediated by deficiency of UCP3. Thus, UCP3-
mediated uncoupling may be physiologically important for min-
imizing production of ROS by skeletal muscle mitochondria.
Increased ROS production in UCP3 KO mice could enhance
oxidative damage to lipids, proteins, and DNA, accelerating the
aging process (59). This possibility will be addressed in future
studies.
In summary, we provide evidence that UCP3 KO mice are
apparently healthy animals but have increased coupling of
mitochondrial respiration in skeletal muscle mitochondria.
This demonstrates that UCP3, expressed at endogenous levels,
has uncoupling activity. Despite this, UCP3 does not seem to be
required for body weight regulation, normal exercise tolerance,
fatty acid oxidation, or cold-induced thermogenesis. The fact
that genetic disruption of UCP3 does not affect these parame-
ters despite altering mitochondrial coupling raises the possi-
bility that compensatory mechanisms are occurring. We also
show that mitochondria lacking UCP3 produce more ROS, sug-
gesting that one of the functions of UCP3 could be to prevent
excessive oxidative stress in skeletal muscle. The physiological
relevance of this observation will be addressed in future
studies.
Acknowledgments—We thank Dr. Tom Balon for advice on perform-
FIG. 5. Oxidative stress. A, LDCL in isolated skeletal muscle mito-
chondria. LDCL was monitored continuously for 10 min after incuba-
tion of mitochondria with 20 mM of lucigenin, as described under “Ex-
perimental Procedures.” Data are expressed as the integrated area
under the curve (46). The values represent the mean 6 S.E. of 4 mice,
p 5 0.0029; unpaired Student’s t test. Shown is a representative exper-
iment validating the LDCL assay. Skeletal muscle mitochondria from
WT mice were incubated with 1 mM ADP, 0.5 mM SC52608 (SC), or 1 mM
FCCP. Also shown is LDCL from skeletal muscle mitochondria isolated
from UCP3 KO mice. B, LDCL in yeast mitochondria-expressing UCP1,
incubated with and without 1 mM GDP. C, aconitase activity in isolated
skeletal muscle mitochondria. Results are expressed as the ratio of
basal aconitase activity to total aconitase activity (48), as described
under “Experimental Procedures.” The values represent the mean 6
S.E. of 6 mice, p , 0.01; unpaired Student’s t test.
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